No Data
No Data
B-cell Lymphoma Pipeline Insight 2024, With Comprehensive Insights for 295+ Companies and 300+ Pipeline Drugs - ResearchAndMarkets.com
Insider Sale: Chief R&D Officer of $NKTR (NKTR) Sells 7,785 Shares
Nektar Therapeutics Presents First Preclinical Data From Novel CSF-1 Program, NKTR-422, At 2024 American College Of Rheumatology Convergence; NKTR-422 Demonstrated Inflammation Resolution And Tissue Repair In Multiple Preclinical Models Of Chronic...
Getting In Cheap On Nektar Therapeutics (NASDAQ:NKTR) Is Unlikely
Nektar Therapeutics Presents First Preclinical Data From Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
Nektar Therapeutics To Present At UBS Global Healthcare Conference; Webcast At 1:15 PM ET